BioAtla, Inc. (NASDAQ: BCAB) reports 2026 annual meeting vote results
Rhea-AI Filing Summary
BioAtla, Inc. held its 2026 annual meeting of stockholders on July 16, 2026, with 906,983 shares of common stock represented in person virtually or by proxy, approximately 55% of the total outstanding shares eligible to be voted. Stockholders considered director elections, auditor ratification and executive compensation.
Two Class III directors, Jay M. Short, Ph.D. and Edward Williams, were elected to three-year terms. Stockholders ratified Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. A non-binding advisory resolution approving the compensation of named executive officers also received stockholder approval.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Shares represented at meeting: 906,983 shares
Meeting participation percentage: 55%
Votes for Jay M. Short, Ph.D.: 313,903 votes
+3 more
6 metrics
Shares represented at meeting
906,983 shares
Approximately 55% of total outstanding shares eligible to be voted at the July 16, 2026 annual meeting
Meeting participation percentage
55%
Portion of total outstanding shares eligible to be voted that were present in person virtually or by proxy
Votes for Jay M. Short, Ph.D.
313,903 votes
Votes cast for election as a Class III director, with 132,916 votes withheld and 460,164 broker non-votes
Votes for Edward Williams
309,949 votes
Votes cast for election as a Class III director, with 136,870 votes withheld and 460,164 broker non-votes
Auditor ratification votes for
869,667 votes
Votes in favor of ratifying Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026
Say-on-pay votes for
281,294 votes
Votes in favor of non-binding advisory resolution on compensation of named executive officers
Key Terms
broker non-votes, non-binding advisory vote, independent registered public accounting firm, emerging growth company
4 terms
broker non-votes financial
"Votes For | Votes Against | Abstentions | Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
non-binding advisory vote financial
"Proposal Three - Non-Binding Advisory Vote on the Executive Compensation"
A non-binding advisory vote is a shareholder vote that expresses investors’ opinion on a proposal (such as executive pay, corporate policy, or governance practices) but does not legally force the company to act. Think of it like a customer survey: it signals whether owners approve or disapprove and can pressure boards and managers to change course, so investors watch the result as an indicator of governance risk and potential future shifts in company strategy or leadership.
independent registered public accounting firm financial
"ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
emerging growth company financial
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What was voted on at BioAtla (BCAB)'s 2026 annual meeting?
Stockholders voted on three proposals: election of two Class III directors, ratification of Ernst & Young LLP as independent registered public accounting firm, and a non-binding advisory vote on compensation of named executive officers.
Were BioAtla (BCAB) Class III director nominees elected, and with how many votes?
Yes. Jay M. Short, Ph.D. received 313,903 votes for and 132,916 withheld, with 460,164 broker non-votes. Edward Williams received 309,949 votes for and 136,870 withheld, with 460,164 broker non-votes, and both were elected to three-year terms.
Did BioAtla (BCAB) stockholders ratify Ernst & Young as auditor for 2026?
Yes. Stockholders ratified Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, with 869,667 votes for, 18,545 votes against, and 18,771 abstentions.
How did BioAtla (BCAB) stockholders vote on executive compensation in 2026?
Stockholders approved, on a non-binding advisory basis, the compensation of named executive officers, with 281,294 votes for, 96,492 against, 69,033 abstentions and 460,164 broker non-votes recorded on the say-on-pay proposal.
Was there a quorum for BioAtla (BCAB)'s 2026 annual stockholder meeting?
Yes. The presence of 906,983 shares, approximately 55% of the total outstanding shares eligible to be voted, constituted sufficient participation for the company to conduct business and record final voting results on all proposals.